63 related articles for article (PubMed ID: 2069475)
1. [High-dose methotrexate and hyperphenylalaninemia].
Dhondt JL; Farriaux JP; Millot F; Taret S; Hayte JM; Mazingue F
Arch Fr Pediatr; 1991 Apr; 48(4):249-51. PubMed ID: 2069475
[TBL] [Abstract][Full Text] [Related]
2. [Early neurotoxicity of high-dose of methotrexate and tetrahydrobiopterin deficiency].
Netter JC; Dhondt JL; Rance F; Petrus M
Arch Fr Pediatr; 1991 Dec; 48(10):719-22. PubMed ID: 1793349
[TBL] [Abstract][Full Text] [Related]
3. Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate.
Millot F; Dhondt JL; Mazingue F; Mechinaud F; Ingrand P; Guilhot F
Pediatr Res; 1995 Feb; 37(2):151-4. PubMed ID: 7537364
[TBL] [Abstract][Full Text] [Related]
4. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
[TBL] [Abstract][Full Text] [Related]
5. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.
Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S
N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251
[TBL] [Abstract][Full Text] [Related]
6. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
[TBL] [Abstract][Full Text] [Related]
7. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
8. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502
[TBL] [Abstract][Full Text] [Related]
9. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.
Totan M; Dagdemir A; Ak AR; Albayrak D; Kucukoduk S
Med Pediatr Oncol; 2001 Apr; 36(4):429-33. PubMed ID: 11260565
[TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).
Skärby T; Jönsson P; Hjorth L; Behrentz M; Björk O; Forestier E; Jarfelt M; Lönnerholm G; Höglund P
Cancer Chemother Pharmacol; 2003 Apr; 51(4):311-20. PubMed ID: 12721759
[TBL] [Abstract][Full Text] [Related]
11. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and impact of unanticipated variation in intravenous methotrexate dosing.
Parshuram CS; Dupuis LL; To T; Weitzman SS; Koren G; Laupacis A
Ann Pharmacother; 2006 May; 40(5):805-11. PubMed ID: 16638922
[TBL] [Abstract][Full Text] [Related]
13. [Measurement in samples of dry blood of dihydropteridine reductase and ratio of total biopterin in hyperphenylalaninemia and other neurological diseases].
Leeming RJ; Karim AR; Sahota AS; Blair JA; Green A
Arch Fr Pediatr; 1987; 44 Suppl 1():649-54. PubMed ID: 3449009
[No Abstract] [Full Text] [Related]
14. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
Vlacha V; Eliopoulou M; Haidas S; Beratis NG
Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions.
Broxson EH; Stork LC; Allen RH; Stabler SP; Kolhouse JF
Cancer Res; 1989 Nov; 49(21):5879-83. PubMed ID: 2790801
[TBL] [Abstract][Full Text] [Related]
16. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by measurement of oxidized and reduced pterins in urine.
Milstien S; Kaufman S; Summer GK
Pediatrics; 1980 Apr; 65(4):806-10. PubMed ID: 7367090
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
Rodman JH; Sunderland M; Kavanagh RL; Ochs J; Yalowich J; Evans WE; Rivera GK
Cancer Res; 1990 Jul; 50(14):4267-71. PubMed ID: 2194652
[TBL] [Abstract][Full Text] [Related]
18. [Serial spectral EEG analysis in children treated with intermediate-dose methotrexate (ID-MTX)].
Fujii Y; Hongo T; Igarashi Y
Rinsho Ketsueki; 1988 Nov; 29(11):2062-7. PubMed ID: 3236413
[No Abstract] [Full Text] [Related]
19. [Assessment of elimination and tolerance of high dose of methotrexate (3 g/m2) in children with standard-risk acute lymphoblastic leukemia].
Cwliklińska M; Balwierz W; Nowak J; Stanuch H
Przegl Lek; 2006; 63(1):15-20. PubMed ID: 16892893
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia.
Fisgin T; Yarali N; Kara A; Bozkurt C; Birgen D; Erten U; Duru F
Pediatr Hematol Oncol; 2004; 21(1):77-83. PubMed ID: 14660309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
